+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030- Product Image
Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030- Product Image
Sale

Synthetic Hormones Market by Hormone Class, Application, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533197
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Synthetic Hormones Market grew from USD 1.02 billion in 2024 to USD 1.17 billion in 2025. It is expected to continue growing at a CAGR of 14.52%, reaching USD 2.31 billion by 2030.

Navigating the Synthetic Hormones Terrain

The synthetic hormones market has become an indispensable pillar of modern therapeutics, providing critical interventions for conditions ranging from diabetes to menopausal symptoms. As demographic shifts and lifestyle changes fuel the prevalence of hormone-related disorders, stakeholders across the pharmaceutical value chain are intensifying efforts to enhance safety profiles, improve delivery mechanisms, and extend patient outreach. This landscape demands rigorous analysis to ensure that product pipelines and manufacturing infrastructures align with evolving needs.

Rising incidence of endocrine disorders has prompted accelerated research into novel hormone analogues and biosimilars. Manufacturers are channeling resources into advanced formulation science, while regulatory bodies scrutinize quality standards more closely than ever. Concurrently, healthcare providers strive to integrate refined treatment protocols into practice, bolstered by real-world evidence and patient-centric care models.

Amidst these converging dynamics, this executive summary distills key trends, competitive pressures, and strategic imperatives shaping the synthetic hormones arena. Through a blend of market segmentation, regional insights, and tariff impact analysis, decision-makers will gain a comprehensive view of current shifts and emerging opportunities. The objective is to equip industry leaders with actionable intelligence that supports robust portfolio planning and sustainable growth.

Emerging Forces Reshaping Hormone Therapy Landscape

The synthetic hormones sector is experiencing transformative shifts driven by the convergence of regulatory evolution, technological breakthroughs, and patient empowerment initiatives. Recent revisions in approval pathways are encouraging manufacturers to adopt more streamlined processes, simultaneously raising the bar for evidence generation. These regulatory adjustments coexist with breakthroughs in drug delivery, where long-acting injectables and transdermal systems are redefining patient adherence and clinical outcomes.

Digital health is reshaping the therapeutic continuum, enabling remote monitoring of hormone levels and facilitating virtual consultations that accelerate titration and mitigate adverse effects. This integration of telemedicine and mobile health applications is fostering a more connected patient journey, where insights gleaned from real-time data inform personalized dosing strategies.

In parallel, value-based care models are gaining traction, prompting collaborations between payers and producers to link reimbursement to clinical efficacy. This pivot toward outcome-driven contracts is incentivizing innovations that demonstrate tangible improvements in quality of life and cost-efficiency. Through these dynamic forces, the industry is charting a new course focused on precision, patient-centricity, and regulatory agility.

Assessing the Ripple Effects of US Tariffs in 2025

The introduction of cumulative tariffs in the United States in 2025 has added a new dimension of complexity to the synthetic hormones ecosystem. Designed to protect domestic manufacturing, these duties have driven up production costs for key intermediates and active pharmaceutical ingredients, creating a ripple effect across the supply chain. Distributors and healthcare providers are facing higher procurement expenses, which in turn are influencing pricing negotiations and reimbursement strategies.

Supply chain disruptions have underscored vulnerabilities in global sourcing, prompting manufacturers to reassess supplier diversification and onshore certain production processes. Some leading firms are forging strategic alliances with domestic contract development and manufacturing organizations to mitigate exposure to fluctuating duties. Meanwhile, parallel efforts to optimize raw material utilization and scale continuous manufacturing technologies have become central to cost containment.

In the long term, these tariff-induced shifts are accelerating a broader strategic reorientation toward regional supply resilience and vertical integration. Companies that proactively adjust their footprint and enhance operational flexibility will be better positioned to absorb policy-driven shocks while maintaining competitive pricing and delivery reliability.

Deep Dive into Market Segmentation Nuances

The synthetic hormones market is characterized by diverse classes, each with unique therapeutic imperatives and commercial drivers. Estrogen formulations serve both contraceptive and menopausal symptom relief needs, balancing efficacy with tolerability profiles. Insulin remains a life-essential therapy for diabetes management, with ongoing enhancements targeting faster onset and reduced immunogenicity. Thyroid hormone analogues address hypo- and hyperthyroid conditions, demanding precise dose control to maintain metabolic equilibrium.

Application-focused segments reveal nuanced growth dynamics. Contraception strategies are bifurcated into combined oral contraceptives that leverage estrogen-progestin synergies and progestin-only formulations tailored for specific patient populations. Diabetes treatment centers on insulin innovation, while growth hormone deficiency therapies cater to both adult and pediatric cohorts through optimized dosing regimens. Menopausal symptom interventions target hot flashes, bone density preservation in osteoporosis, and vaginal atrophy, each requiring specialized delivery technologies. Thyroid disorder management splits into hyperthyroid and hypothyroid therapies, reflecting divergent biochemical pathways and patient management strategies.

Manufacturing platforms are evolving alongside therapeutic demands. Chemical synthesis routes encompass liquid-phase and solid-phase approaches, offering cost-effective scalability for established molecules. Meanwhile, recombinant DNA technologies utilize bacterial, mammalian cell, and yeast expression systems to produce high-purity biomolecules with precise structural fidelity. These complementary methods are driving efficiency gains and enabling pipeline diversification.

End-user channels exhibit distinct adoption patterns. General practice and specialty clinics remain primary prescription points for hormone therapies, while homecare settings empower patients through nursing services and self-administration models. Private and public hospitals negotiate large-scale tenders for critical hormone supplies. Online pharmacies facilitate over-the-counter and prescription-based distribution, and retail pharmacies-both chain and independent-serve as vital touchpoints for patient education and continuity of supply.

Regional Dynamics Shaping Global Growth

Regional heterogeneity underscores the synthetic hormones market’s complexity and opportunity landscape. In the Americas, robust healthcare infrastructures and favorable reimbursement frameworks in the United States and Canada have fostered rapid uptake of next-generation therapies, while Latin American markets are gradually enhancing access through public-private partnerships and pricing reforms. This region continues to lead in clinical research investments and early adoption of digital health solutions.

Europe, the Middle East and Africa region presents a tapestry of regulatory environments and market maturities. The European Union’s harmonized approval processes and centralized tender systems streamline market entry but also impose stringent price controls. Gulf Cooperation Council countries and southern Africa are investing in local manufacturing capabilities to reduce import dependence, even as budget constraints drive cost-containment measures.

Asia-Pacific is emerging as a high-growth frontier, propelled by expanding healthcare coverage in China and India, government incentives for biopharmaceutical innovation, and rising patient awareness of hormone-related conditions. Southeast Asian markets are leveraging generics and biosimilars to extend treatment penetration, while Australia and Japan remain hubs for cutting-edge R&D and precision medicine applications.

Competitive Landscape and Collaborations Driving Innovation

The competitive arena of synthetic hormones is defined by a cadre of leading biopharmaceutical companies pursuing differentiated pipelines and strategic collaborations. Industry frontrunners are investing in next-generation formulations that offer extended-release profiles, reduced injection frequencies, and improved safety margins. Licensing agreements and joint ventures are enhancing access to proprietary technologies, particularly in emerging markets where local partnerships facilitate regulatory navigation and distribution scale.

Acquisitions remain a key vehicle for expanding capabilities, with several major players integrating specialized contract manufacturing organizations and niche biotech firms to bolster capacity and diversify product portfolios. R&D alliances with academic institutions and research consortia are fueling innovation in both small-molecule synthesis and biologics manufacturing. These synergies are critical for translating advanced expression systems and formulation breakthroughs into commercial success.

Strategic Playbook for Industry Leaders

To thrive amid policy shifts and intensifying competition, industry leaders must prioritize supply chain resilience by establishing regional manufacturing hubs and diversifying raw material sources. Investing in recombinant DNA platforms will accelerate the development of high-purity hormone biologics, while continuous manufacturing technologies can unlock cost efficiencies and reduce time-to-market. Embracing digital health solutions-such as remote hormone level monitoring and smart delivery devices-will enhance treatment adherence and differentiate offerings in value-based care environments.

Tailoring strategies to regional market dynamics is imperative. Engaging payers through outcome-based pricing agreements can secure sustainable reimbursement in mature markets, while forging alliances with local distributors and healthcare providers will fast-track access in growth regions. Collaboration with regulatory agencies to streamline approval pathways and ensure quality compliance will further solidify market positioning.

Rigorous Methodology Underpinning Our Analysis

This analysis was developed through a rigorous methodology integrating multiple data sources and validation steps. Primary research included in-depth interviews with endocrinologists, formulators, regulatory experts, and supply chain executives, providing firsthand perspectives on market dynamics and emerging trends. Secondary research encompassed a comprehensive review of regulatory filings, peer-reviewed journals, company presentations, and industry databases to ensure a robust foundation of quantitative and qualitative insights.

Data triangulation techniques were applied to reconcile disparate information streams, ensuring consistency across therapeutic, technological, and regional dimensions. Expert panels conducted validation workshops to assess the relevance and accuracy of findings, while structured quality checks and editorial reviews guaranteed clarity and coherence. This methodological rigor underpins the credibility of the conclusions and recommendations presented herein.

Synthesizing Insights into a Cohesive Conclusion

The synthetic hormones sector is at an inflection point, shaped by evolving regulatory landscapes, technological advancements, and shifting market dynamics. Cumulative tariffs in the United States, segmented therapeutic demands, and regional heterogeneity collectively create both challenges and opportunities for industry stakeholders. Success in this environment will depend on agility, strategic partnerships, and continued investment in innovation.

By aligning product development and manufacturing strategies with the nuanced needs of distinct hormone classes, applications, technologies, and end users, companies can position themselves for sustained growth. Proactive engagement with payers, regulators, and local partners will be essential to navigate policy shifts and unlock new market potential. The insights distilled in this executive summary serve as a strategic compass, guiding decision-makers toward informed actions in a rapidly evolving therapeutic landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Hormone Class
    • Estrogen
    • Insulin
    • Thyroid
  • Application
    • Contraception
      • Combined Oral Contraceptive
      • Progestin Only Contraceptive
    • Diabetes
    • Growth Hormone Deficiency
      • Adult GHD
      • Pediatric GHD
    • Menopausal Symptoms
      • Hot Flashes
      • Osteoporosis
      • Vaginal Atrophy
    • Thyroid Disorders
      • Hyperthyroidism
      • Hypothyroidism
  • Technology
    • Chemical Synthesis
      • Liquid-Phase Synthesis
      • Solid-Phase Synthesis
    • Recombinant Dna Technology
      • Bacterial Expression Systems
      • Mammalian Cell Expression Systems
      • Yeast Expression Systems
  • End User
    • Clinics
      • General Practice Clinics
      • Specialty Clinics
    • Homecare Settings
      • Nursing Service
      • Self-Administration
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Online Pharmacies
      • Over-The-Counter
      • Prescription-Based
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Ferring Pharmaceuticals S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • AbbVie Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Hormones Market, by Hormone Class
8.1. Introduction
8.2. Estrogen
8.3. Insulin
8.4. Thyroid
9. Synthetic Hormones Market, by Application
9.1. Introduction
9.2. Contraception
9.2.1. Combined Oral Contraceptive
9.2.2. Progestin Only Contraceptive
9.3. Diabetes
9.4. Growth Hormone Deficiency
9.4.1. Adult GHD
9.4.2. Pediatric GHD
9.5. Menopausal Symptoms
9.5.1. Hot Flashes
9.5.2. Osteoporosis
9.5.3. Vaginal Atrophy
9.6. Thyroid Disorders
9.6.1. Hyperthyroidism
9.6.2. Hypothyroidism
10. Synthetic Hormones Market, by Technology
10.1. Introduction
10.2. Chemical Synthesis
10.2.1. Liquid-Phase Synthesis
10.2.2. Solid-Phase Synthesis
10.3. Recombinant Dna Technology
10.3.1. Bacterial Expression Systems
10.3.2. Mammalian Cell Expression Systems
10.3.3. Yeast Expression Systems
11. Synthetic Hormones Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Practice Clinics
11.2.2. Specialty Clinics
11.3. Homecare Settings
11.3.1. Nursing Service
11.3.2. Self-Administration
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
11.5. Online Pharmacies
11.5.1. Over-The-Counter
11.5.2. Prescription-Based
11.6. Retail Pharmacies
11.6.1. Chain Pharmacies
11.6.2. Independent Pharmacies
12. Americas Synthetic Hormones Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Synthetic Hormones Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Synthetic Hormones Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novo Nordisk A/S
15.3.2. Sanofi S.A.
15.3.3. Eli Lilly and Company
15.3.4. Pfizer Inc.
15.3.5. Ferring Pharmaceuticals S.A.
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Bayer AG
15.3.8. Novartis AG
15.3.9. Merck & Co., Inc.
15.3.10. AbbVie Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SYNTHETIC HORMONES MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC HORMONES MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC HORMONES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN ONLY CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ADULT GHD, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEDIATRIC GHD, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VAGINAL ATROPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NURSING SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 95. CANADA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 96. CANADA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 97. CANADA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 100. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 103. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 104. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 229. ITALY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 231. ITALY SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 232. ITALY SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 233. ITALY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. ITALY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 236. ITALY SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. ITALY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ITALY SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 240. ITALY SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. ITALY SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. ITALY SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 247. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 257. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 303. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 304. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 307. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 311. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 315. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 317. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 333. QATAR SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2030 (USD MILLION)
TABLE 334. QATAR SYNTHETIC HORMO

Companies Mentioned

The companies profiled in this Synthetic Hormones market report include:
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Ferring Pharmaceuticals S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • AbbVie Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.31 Billion
Compound Annual Growth Rate14.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioidentical Hormones Market by Product Type, End User, Therapy Type, Delivery Method, Age Group, Gender - Global Forecast to 2030 - Product Image

Bioidentical Hormones Market by Product Type, End User, Therapy Type, Delivery Method, Age Group, Gender - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Synthetic Hormones Market Report 2025 - Product Image

Synthetic Hormones Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Image

Hormone Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Human Growth Hormone Market by Application, Type, End User, Distribution Channel, Dosage Form - Global Forecast to 2030 - Product Image

Human Growth Hormone Market by Application, Type, End User, Distribution Channel, Dosage Form - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From

About the Synthetic Hormone Market

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats. Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population. Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.